Go to the page content
ĶMI

Pārbaudiet savu ĶMI ar ĶMI kalkulatoru

Ķermeņa masas indekss (ĶMI) ir rīks, ko bieži izmanto kā ķermeņa tauku netiešu mērījumu un ar ko var veikt aptaukošanās pārbaudi un ar to saistītos veselības riskus.  To var aprēķināt, izmantojot ĶMI kalkulatoru, pamatojoties uz augumu un svaru, un rezultātus var iedalīt dažādās kategorijās, sākot no nepietiekama svara līdz 3. aptaukošanās pakāpei.

3 min. read

Uzziniet savu ĶMI un veselības riskus

ĶMI kalkulators: pārbaudiet savu ĶMI tagad

Izmantojiet ĶMI kalkulatoru, lai izdalītu svaru kg ar auguma garumu metros kvadrātā un salīdziniet savu rezultātu ar ĶMI kategorijām. Ievadiet savu auguma garumu un svaru un pārbaudiet rezultātus tālāk esošajā tabulā.

Klikšķiniet uz ĶMI kategorijām, lai uzzinātu vairāk.

KategorijaĶMI
Nepietiekams svars<18,5
Normāls svars18,5-24,9
Liekais svars25,0-29,9
Aptaukošanās≥30
1. pakāpe30-34,9
2. pakāpe35-39,9
3. pakāpe≥40

* Klasifikācija, ko sniedz Pasaules Veselības organizācija (PVO). Šis ĶMI kalkulators ir paredzēts pieaugušajiem no 20 gadu vecuma. Konsultējieties ar savu ārstu par ĶMI, ja esat jaunāks par 20 gadiem. ĶMI klasifikācijas pamatā ir PVO ĶMI klasifikācija.

 

Kāpēc ir svarīgi zināt ĶMI?

ĶMI ir labs veids, kā pārbaudīt ar ķermeņa taukiem (aptaukošanos) saistīto slimību risku. Pārsvarā, jo augstāks ir ĶMI, jo lielāka iespēja saslimt ar citām hroniskām aptaukošanās slimībām, tostarp:

  • 2. tipa cukura diabētu
  • Sirds un asinsvadu slimībām
  • Insultu
  • Augstu asinsspiedienu
  • Neauglību
  • Depresiju un trauksmi
  • Koronāru sirds slimību
  • Dislipidēmiju
  • Ar metabolo disfunkciju saistīto steatohepatisko aknu slimību (MASLD)/Ar metabolisko disfunkciju saistīto steatohepatītu (MASH)
  • Gastroezofageālā refluksa slimību (GERS)
  • Metabolo sindromu
  • Urīna nesaturēšanu
  • Obstruktīva miega apnoju un elpošanas problēmas
  • hroniska nieru slimība;
  • dažādu veidu vēzis: ieskaitot, bet ne tikai – krūts, resnās zarnas, endometrija, barības vada, nieru, olnīcu un aizkuņģa dziedzera vēzis;
  • Hronisku nieru slimību
  • Dažādiem vēža veidiem: ieskaitot, bet ne tikai - krūts, resnās zarnas, endometrija, barības vada, nieru, olnīcu un aizkuņģa dziedzera.
  • Ceļa locītavas osteoartrītu
  • Žultsakmeņiem
  • Trombozi
  • Podagru
  • Palielinātu mirstības risku, salīdzinot ar cilvēkiem, kam ir normāls ĶMI

Kādi ir ĶMI ierobežojumi?

ĶMI ir vienkāršs un objektīvs mērījums, taču dažos gadījumos un dažām cilvēku grupām tas var būt maldinošs. Pētījumos ie pierādīts, ka ĶMI ir mazāk precīzs, lai prognozētu slimību risku cilvēkiem, kas ir vecāki, sportistiem, tiem, kas ir gari vai īsi, un tiem, kuriem ir muskuļotāks ķermeņa tips. Piemēram, elites sportistiem vai kultūristiem ir vairāk muskuļu un tie sver vairāk, kas attiecīgi paaugstina ĶMI.

Tāpat ĶMI neņem vērā:

  • Iedzimtus riska faktorus, kas saistīti ar aptaukošanās slimībām, piemēram, metabolo sindromu
  • Vides un dzīvesveida faktorus, kas var veicināt risku saslimt ar hroniskām slimībām
  • Kurās ķermeņa daļās ir uzkrāti tauki

Ir svarīgi atcerēties, ka dzīve ar aptaukošanos ne vienmēr nozīmē, ka jūs esat neveselīgs, tāpat kā “normāls” svars ne vienmēr nozīmē, ka esat veselīgs.

Kā ĶMI un vidukļa attiecība pret auguma garumu var palīdzēt pārvaldīt sirds veselību


Cilvēkiem ar lieko svaru vai aptaukošanos ir lielāks risks saslimt ar kardiovaskulārajām slimībām (KVS), ko sauc arī par sirds slimībām.

Lai gan ĶMI un vidukļa attiecību pret auguma garumu (WtHR — Waist to Height Ratio) var izmantot, lai novērtētu personas KVS attīstības risku, WtHR tiek uzskatīts par spēcīgāku prognozētāju sirds un asinsvadu riska faktoriem, piemēram, augsta asinsspiedienam un augstam holesterīnam. 

ĶMI izmanto, lai norādītu personas svara kategoriju, pamatojoties uz to garumu un svaru. WtHR savukārt tiek izmantots, lai izmērītu cilvēka ķermeņa tauku sadalījumu, pamatojoties uz to augumu un vidukļa apkārtmēru. WtHR mērīšana ir svarīga, jo pārmērīgs tauku daudzums, kas tiek uzkrāts ap vēderu, jo īpaši ir saistīts ar paaugstinātu sirds slimību attīstības risku.

Gan sava ĶMI, gan WtHR zināšana var palīdzēt jums uzlabot savu sirds veselību, saprotot, vai ir jāveic pasākumi, lai pārvaldītu savu svaru.

Noklikšķiniet šeit, lai aprēķinātu vidukļa un auguma garuma attiecību un to, ko tas nozīmē jums.

 

Atsauces:
  • Lopez-Jimenez F, Almahmeed W, Bays H, et al. Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation. Eur J Prev Cardiol. 2022 Dec 7;29(17):2218-2237. doi: 10.1093/eurjpc/zwac187. PMID: 36007112.
  • Zhang, S., Fu, X., Du, Z. et al. Is waist-to-height ratio the best predictive indicator of cardiovascular disease incidence in hypertensive adults? A cohort study. BMC Cardiovasc Disord 22, 214 (2022). https://doi.org/10.1186/s12872-022-02646-1
  • Rueda-Clausen, C F et al, “Assessment of People Living with Obesity,”Can. Adult Obes. Clin. Pract. Guidel., pp. 1–17, 2020, [tiešsaistē]. Pieejams: http://obesitycanada.ca/wp-content/uploads/2020/09/6-Obesity-Assessment-v5-with-links.pdf.
  • Yumuk, V et al, “European Guidelines for Obesity Management in Adults” Obes Facts. 2015 Dec; 8(6): 402–424. Publicēta tiešsaistē 2015. gada 5. decembrī. doi: 10.1159/000442721.
  • Garvey, W T et al, “American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity.” Endocrine Practice 2016;22:1–203. DOI:https://doi.org/10.4158/EP161365.GL
  • Guh, D P et al, “The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis,” BMC Public Health, vol. 9, no. 1, p. 88, 2009, doi: 10.1186/1471-2458-9-88.
  • Prospective Studies Collaboration, “Body-mass index and cause-specific mortality in 900000 adults: collaborative analyses of 57 prospective studies,” Lancet, vol. 373, no. 9669, pp. 1083–1096, Mar. 2009, doi: 10.1016/S0140-6736(09)60318-4.
  • “Obesity Screening – Medline Plus, U.S. National Library of Medicine” Pieejams: https://medlineplus.gov/lab-tests/obesity-screening/.
  • “Assessing Your Weight and Health Risk – National Heart, Lung, and Blood Association – U.S. Department of Health & Human Services” Pieejams: https://www.nhlbi.nih.gov/health/educational/lose_wt/risk.htm.
  • Hussain, A et al, “Type 2 Diabetes and obesity: A review” Journal of Diabetology, June 2010; 2:1.
  • Katzmarzyk, P T et al, “Body mass index and risk of cardiovascular disease, cancer and all-cause mortality” Can. J. Public Health, vol. 103, no. 2, pp. 147–151, 2012, doi: 10.1007/BF03404221.
  • Kurth, T et al, “Prospective Study of Body Mass Index and Risk of Stroke in Apparently Healthy Women,” Circulation, vol. 111, no. 15, pp. 1992–1998, Apr. 2005, doi: 10.1161/01.CIR.0000161822.83163.B6.
  • Landi, F et al, “Body Mass Index is Strongly Associated with Hypertension: Results from the Longevity Check-Up 7+ Study” Nutrients. 2018 Dec; 10(12): 1976. Publicēts tiešsaistē 2018. gada 13. decembrī. doi: 10.3390/nu10121976
  • Dağ, Z Ö et al, “Impact of obesity on infertility in women,” J. Turkish Ger. Gynecol. Assoc., vol. 16, no. 2, pp. 111–117, Jun. 2015, doi: 10.5152/jtgga.2015.15232.
  • Moussa, O M et al, “Effect of body mass index on depression in a UK cohort of 363037 obese patients: A longitudinal analysis of transition,” Clin. Obes., vol. 9, no. 3, p. e12305, Jun. 2019, doi: https://doi.org/10.1111/cob.12305.
  • Zhao, G et al, “Depression and anxiety among US adults: associations with body mass index,” Int. J. Obes., vol. 33, no. 2, pp. 257–266, 2009, doi: 10.1038/ijo.2008.268.
  • Lamon-Fava, S et al, “Impact of Body Mass Index on Coronary Heart Disease Risk Factors in Men and Women,” Arterioscler. Thromb. Vasc. Biol., vol. 16, no. 12, pp. 1509–1515, Dec. 1996, doi: 10.1161/01.ATV.16.12.1509.
  • Van Hemelrijck, M et al, “Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60,000 men and women in Sweden and Austria” Publicēts: 2018. gada 13. jūnijs https://doi.org/10.1371/journal.pone.0197830.
  • Loomis, A K et al, “Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies,” J. Clin. Endocrinol. Metab., vol. 101, no. 3, pp. 945–952, Mar. 2016, doi: 10.1210/jc.2015-3444.
  • Zafar, S et al, “Correlation of gastroesophageal reflux disease symptoms with body mass index,” Saudi J. Gastroenterol., vol. 14, no. 2, pp. 53–57, Apr. 2008, doi: 10.4103/1319-3767.39618.
  • Han, T S et al, “A clinical perspective of obesity, metabolic syndrome and cardiovascular disease,” JRSM Cardiovasc. Dis., vol. 5, pp. 2048004016633371–2048004016633371, Feb. 2016, doi: 10.1177/2048004016633371.
  • Subak, L L et al, “Obesity and Urinary Incontinence: Epidemiology and Clinical Research Update” J Urol. 2009 Dec; 182(6 Suppl): S2–S7 doi: 10.1016/j.juro.2009.08.071.
  • Romero-Corral, A et al, “Interactions Between Obesity and Obstructive Sleep Apnea - Implications for Treatment” Chest. 2010 Mar; 137(3): 711–719. doi: 10.1378/chest.09-0360.
  • Herrington, W G et al, “Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England,” PLoS One, vol. 12, no. 3, p. e0173515, Mar. 2017, [Tiešsaistē]. Pieejams: https://doi.org/10.1371/journal.pone.0173515.
  • Bhaskaran, K et al, “Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults,” Lancet, vol. 384, no. 9945, pp. 755–765, Aug. 2014, doi: 10.1016/S0140-6736(14)60892-8.
  • Zheng, H et al, “Body mass index and risk of knee osteoarthritis: Systematic review and meta-analysis of prospective studies,” BMJ Open, vol. 5, no. 12, 2015, doi: 10.1136/bmjopen-2014-007568.
  • Su, Y P et al, “Strong association between metabolically-abnormal obesity and gallstone disease in adults under 50 years” BMC Gastroenterol 19, 117 (2019). https://doi.org/10.1186/s12876-019-1032-y.
  • Yang, G et al, “The effects of obesity on venous thromboembolism: A review” Open J Prev Med. 2012 Nov; 2(4): 499–509. doi: 10.4236/ojpm.2012.24069.
  • Bai, L et al, “Incident gout and weight change patterns: a retrospective cohort study of US adults” Arthritis Res Ther. 2021; 23: 69. Publicēts tiešsaistē 2021  gada 2. martā. doi: 10.1186/s13075-021-02461-7.
  • Klatsky, A L et al, “Body Mass Index and Mortality in a Very Large Cohort: Is It Really Healthier to Be Overweight?,” Perm. J., vol. 21, pp. 16–142, 2017, doi: 10.7812/TPP/16-142.
  • Heymsfield, S B et al,“Why are there race/ethnic differences in adult body mass index-adiposity relationships? A quantitative critical review,” Obes. Rev., vol. 17, no. 3, pp. 262–275, Mar. 2016, doi: 10.1111/obr.12358.
  • “Ethnic Differences in BMI and Disease Risk | Obesity Prevention Source | Harvard T.H. Chan School of Public Health.” [Tiešsaistē]. Pieejams: https://www.hsph.harvard.edu/obesity-prevention-source/ethnic-differences-in-bmi-and-disease-risk/.
  • Cossrow, N et al, “Race/Ethnic Issues in Obesity and Obesity-Related Comorbidities,” J. Clin. Endocrinol. Metab., vol. 89, no. 6, pp. 2590–2594, Jun. 2004, doi: 10.1210/jc.2004-0339.
  • “Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies – Public Health – WHO international” Pieejams: https://www.who.int/nutrition/publications/bmi_asia_strategies.pdf.
  • Deurenberg-Yap, M et al, “The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore.” Int J Obes Relat Metab Disord. 2000 Aug;24(8):1011-7. doi: 10.1038/sj.ijo.0801353. PMID: 10951540.
  • Valentino, G et al, “Body fat and its relationship with clustering of cardiovascular risk factors” Nutr Hosp. 2015;31(5):2253-2260 ISSN 0212-1611 • CODEN NUHOEQ S.V.R. 318.
  • Lear, S A et al, “Ethnic Variation in Fat and Lean Body Mass and the Association with INS Resistance” The Journal of Clinical Endocrinology & Metabolism, Volume 94, Issue 12, 1 December 2009, Pages 4696–4702, https://doi.org/10.1210/jc.2009-1030.
  • Tillin, T et al, “The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans: SABRE (Southall and Brent Revisited) -- a prospective population-based study,” J. Am. Coll. Cardiol., vol. 61, no. 17, pp. 1777–1786, Apr. 2013, doi: 10.1016/j.jacc.2012.12.046.
  • Tanne, D et al, “Body Fat Distribution and Long-Term Risk of Stroke Mortality” Stroke. Sākotnēji publicēts 2005. gada 31. martā https://doi.org/10.1161/01.STR.0000162584.39366.1c.
  • Chen, Y et al, “Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort Consortium,” BMJ Br. Med. J., vol. 347, p. f5446, Oct. 2013, doi: 10.1136/bmj.f5446.
  • Wen, C P et al, “Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians” Public Health Nutrition, 12(4), 497-506. doi:10.1017/S1368980008002802.
  • J. S. for the S. of O. The Examination Committee of Criteria for `Obesity Disease’ in Japan, “New Criteria for `Obesity Disease’ in Japan,” Circ. J., vol. 66, no. 11, pp. 987–992, 2002, doi: 10.1253/circj.66.987.
  • Zheng, W et al, “Association between Body-Mass Index and Risk of Death in More Than 1 Million Asians,” N. Engl. J. Med., vol. 364, no. 8, pp. 719–729, Feb. 2011, doi: 10.1056/NEJMoa1010679.
  • Aekplakorn, W et al, “Obesity indices and cardiovascular risk factors in Thai adults.” Int J Obes 30, 1782–1790 (2006). https://doi.org/10.1038/sj.ijo.0803346.
  • Choi, S E et al, “Do Risk Factors Explain the Increased Prevalence of Type 2 Diabetes Among California Asian Adults?” J Immigr Minor Health. 2011; 13(5): 803–808. Publicēts tiešsaistē 2010. gada 9. oktobrī. doi: 10.1007/s10903-010-9397-6.
  • Swinburn, B et al, “Body size and composition in Polynesians” Int J Obes 23, 1178–1183 (1999). https://doi.org/10.1038/sj.ijo.0801053.
  • Young, D R et al, “Associations of overweight/obesity and socioeconomic status with hypertension prevalence across racial and ethnic groups,” J. Clin. Hypertens., vol. 20, no. 3, pp. 532–540, Mar. 2018, doi: https://doi.org/10.1111/jch.13217.
  • Maskarinec, G et al, “Diabetes Prevalence and Body Mass Index Differ by Ethnicity: The Multiethnic Cohort” Ethn Dis. 2009; 19(1): 49–55. PMCID: PMC2702477.
  • Aleman-Mateo, H et al, “Elderly Mexicans have less muscle and greater total and truncel fat compared to African-Americans and Caucasians with the same BMI” J Nutr Health Aging. 2009 Dec; 13(10): 919. doi: 10.1007/s12603-009-0252-1.
  • Cossrow, N et al, “Race/Ethnic Issues in Obesity and Obesity-Related Comorbidities” The Journal of Clinical Endocrinology & Metabolism, Volume 89, Issue 6, 1 June 2004, Pages 2590–2594, https://doi.org/10.1210/jc.2004-0339.
  • Berber, A et al, “Anthropometric indexes in the prediction of type 2 diabetes mellitus, hypertension and dyslipidaemia in a Mexican population,” Int. J. Obes., vol. 25, no. 12, pp. 1794–1799, 2001, doi: 10.1038/sj.ijo.0801827.
  • Chirinos, D A et al, “Defining Abdominal Obesity as a Risk Factor for Coronary Heart Disease in the U.S.: Results From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)” Diabetes Care Aug 2020, 43 (8) 1774-1780; DOI: 10.2337/dc19-1855.
  • Elo, I T et al, “The Contribution of Weight Status to Black-White Differences in Mortality” Biodemography Soc Biol. 2017; 63(3): 206–220. doi: 10.1080/19485565.2017.1300519.
  • “9 The evidence | BMI: preventing ill health and premature death in black, Asian and other minority ethnic groups | Guidance | NICE.” [Tiešsaistē]. Pieejams: https://www.nice.org.uk/guidance/ph46/chapter/9-The-evidence.
  • Alammar, M et al, “Diagnostic Accuracy of Body Mass Index (BMI) When Diagnosing Obesity in a Saudi Adult Population in a Primary Care Setting, Cross Sectional, Retrospective Study” Diabetes Metab Syndr Obes. 2020; 13: 2515–2520. Publicēts tiešsaistē 2020. gada 14. jūlijā. doi: 10.2147/DMSO.S263063.
  • Bennet, L et al, “BMI and waist circumference cut-offs for corresponding levels of INS sensitivity in a Middle Eastern immigrant versus a native Swedish population – the MEDIM population based study” BMC Public Health. 2016; 16: 1242. Publicēts tiešsaistē 2016. gada 9. decembrī. doi: 10.1186/s12889-016-3892-1.
  • Al-Raddadi, R et al, “The prevalence of obesity and overweight, associated demographic and lifestyle factors, and health status in the adult population of Jeddah, Saudi Arabia,” Ther. Adv. Chronic Dis., vol. 10, p. 2040622319878997, Jan. 2019, doi: 10.1177/2040622319878997.
  • Abell, J E et al, “Differences in Cardiovascular Disease Mortality Associated With Body Mass Between Black and White Persons,” Am. J. Public Health, vol. 98, no. 1, pp. 63–66, Jan. 2008, doi: 10.2105/AJPH.2006.093781.
  • Batsis, J A et al, “Diagnostic Accuracy of Body Mass Index to Identify Obesity in Older Adults: NHANES 1999–2004” Int J Obes (Lond). 2016 May; 40(5): 761–767. Publicēts tiešsaistē 2015. gada 1. decembrī. doi: 10.1038/ijo.2015.243
  • Michigan State University. "BMI Not Accurate Indicator Of Body Fat, New Research Suggests." ScienceDaily. ScienceDaily, 2007. gada 7. marts. Pieejams: www.sciencedaily.com/releases/2007/03/070305202535.htm.
  • Sperrin, M et al, “Body mass index relates weight to height differently in women and older adults: serial cross-sectional surveys in England (1992-2011)” J. Public Health (Oxf)., vol. 38, no. 3, pp. 607–613, Sep. 2016, doi: 10.1093/pubmed/fdv067.
  • Weir CB, et al, “BMI Classification Percentile And Cut Off Points.” In: StatPearls [Internets]. Treasure Island (FL): StatPearls Publishing; 2021 Jan.
  • “What Is My Ideal Body Fat Percentage? - Healthline” [Tiešsaistē] Pieejams: https://www.healthline.com/health/exercise-fitness/ideal-body-fat-percentage.
  • Nuttall, F Q. “Body Mass Index: Obesity, BMI, and Health: A Critical Review” Nutr Today. 2015 May; 50(3): 117–128. Publicēts tiešsaistē 2015. gada 7. aprīlis. doi: 10.1097/NT.0000000000000092.
  • Karastergiou, K et al, “Sex differences in human adipose tissues – the biology of pear shape,” Biol. Sex Differ., vol. 3, no. 1, p. 13, 2012, doi: 10.1186/2042-6410-3-13.
  • Nauli, A M et al, “Why Do Men Accumulate Abdominal Visceral Fat?” Front. Physiol., vol. 10, p. 1486, Dec. 2019, doi: 10.3389/fphys.2019.01486.
  • Thorpe Jr., R J et al, “Aging, Obesity, and Mortality: Misplaced Concern About Obese Older People?” Res Aging. 2004. gada 1. janvāris; 26(1): 108–129. doi: 10.1177/0164027503258738.
  • Yanovski, J A “Pediatric obesity. An introduction” Appetite. 2015. gada 1. oktobris; 93: 3–12. Publicēts tiešsaistē 2015. gada 30. marts. doi: 10.1016/j.appet.2015.03.028.
  • “About Child & Teen BMI – Center for Disease Control and Prevention” Pieejams: https://www.cdc.gov/healthyweight/assessing/bmi/childrens_bmi/about_childrens_bmi.html.
  • Chung, S “Growth and Puberty in Obese Children and Implications of Body Composition” J Obes Metab Syndr. 2017 Dec; 26(4): 243–250. Publicēts tiešsaistē 2017. gada 30. decembris. doi: 10.7570/jomes.2017.26.4.243.
  • St-Onge, M P et al, “Body composition changes with aging: The cause or the result of alterations in metabolic rate and macronutrient oxidation?” Nutrition. 2010 Feb; 26(2): 152–155. Publicēts tiešsaistē 2009. gada 8. decembrī. doi: 10.1016/j.nut.2009.07.004.
  • Studenski, S A et al, “The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates,” J. Gerontol. A. Biol. Sci. Med. Sci., vol. 69, no. 5, pp. 547–558, May 2014, doi: 10.1093/gerona/glu010.
  • McKee, A et al, “Obesity in the Elderly” In: Endotext [Internets]. South Dartmouth (MA): MDText.com, Inc.; 2000.
  • Van Der Valk, E S et al, “A comprehensive diagnostic approach to detect underlying causes of obesity in adults” Obesity Reviews Pirmā publikācija: 2019. gada 1. marts https://doi.org/10.1111/obr.12836.
  • Hetherington-Rauth, M et al, “Comparison of direct measures of adiposity with indirect measures for assessing cardiometabolic risk factors in preadolescent girls” Nutr J. 2017; 16: 15. Publicēts tiešsaistē 2017. gada 23. februārī. doi: 10.1186/s12937-017-0236-7.
  • Janssen, I et al, “Waist circumference and not body mass index explains obesity-related health risk” The American Journal of Clinical Nutrition, Volume 79, Issue 3, March 2004, Pages 379–384, https://doi.org/10.1093/ajcn/79.3.379.
  • Robert Ross et al, “Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity” Nat Rev Endocrinol. 2020; 16(3): 177–189. Publicēts tiešsaistē 2020. gada 4. februārī. doi: 10.1038/s41574-019-0310-7.
  • “Why is my waist size important? - NHS.” [Tiešsaistē]. Pieejams: https://www.nhs.uk/common-health-questions/lifestyle/why-is-my-waist-size-important/.
  • “Metabolic syndrome - Symptoms and causes - Mayo Clinic.” [Tiešsaistē]. Pieejams: https://www.mayoclinic.org/diseases-conditions/metabolic-syndrome/symptoms-causes/syc-20351916.
  • “Metabolic Syndrome – Cedars Sinai” [Online]. Pieejams: https://www.cedars-sinai.org/health-library/diseases-and-conditions/m/metabolic-syndrome.html.
  • “Metabolic Syndrome | NHLBI, NIH.” [Tiešsaistē]. Pieejams: https://www.nhlbi.nih.gov/health-topics/metabolic-syndrome.
  • “HDL cholesterol: How to boost your ‘good’ cholesterol - Mayo Clinic.” [Tiešsaistē]. Pieejams: https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/hdl-cholesterol/art-20046388.
  • Yanai, H et al, “The underlying mechanisms for development of hypertension in the metabolic syndrome” Nutr J. 2008; 7: 10. Publicēts tiešsaistē 2008. gada 17. aprīlis. doi: 10.1186/1475-2891-7-10.
  • “What is Cardiovascular Disease? | American Heart Association.” [Tiešsaistē]. Pieejams: https://www.heart.org/en/health-topics/consumer-healthcare/what-is-cardiovascular-disease
  • “Type 2 Diabetes - Symptoms | ADA.” [Tiešsaistē]. Pieejams: https://www.diabetes.org/diabetes/type-2/symptoms.
  • Arenillas, J F et al, “The Metabolic Syndrome and Stroke - Potential Treatment Approaches” Stroke Sākotnēji publicēts 2007. gada 31. maijā https://doi.org/10.1161/STROKEAHA.106.480004.
  • Lin, H et al, “The prevalence, metabolic risk and effects of lifestyle intervention for metabolically healthy obesity: a systematic review and meta-analysis: A PRISMA-compliant article” Medicine (Baltimore). 2017 Nov; 96(47): e8838. Publicēts tiešsaistē 2017. gada 27. novembrī. doi: 10.1097/MD.0000000000008838.
  • Hinnouho, G M et al, “Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?,” Diabetes Care, vol. 36, no. 8, pp. 2294–2300, Aug. 2013, doi: 10.2337/dc12-1654.
  • Eknoyan, G. “Adolphe Quetelet (1796–1874) — the average man and indices of obesity” Nephrology Dialysis Transplantation, Volume 23, Issue 1, January 2008, Pages 47–51, https://doi.org/10.1093/ndt/gfm517.
  • Abou Ziki, M D et al, “Metabolic Syndrome: Genetic Insights into Disease Pathogenesis” Curr Opin Lipidol. 2016 Apr; 27(2): 162–171. doi: 10.1097/MOL.0000000000000276.
  • Kolb, H et al, “Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes.” BMC Med 15, 131 (2017). https://doi.org/10.1186/s12916-017-0901-x.
  • Jensen, M D “Role of Body Fat Distribution and the Metabolic Complications of Obesity” J Clin Endocrinol Metab. 2008 Nov; 93(11 Suppl 1): S57–S63. doi: 10.1210/jc.2008-1585.
  • Wildman, R P et al, “The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering: Prevalence and Correlates of 2 Phenotypes Among the US Population (NHANES 1999-2004),” Arch. Intern. Med., vol. 168, no. 15, pp. 1617–1624, Aug. 2008, doi: 10.1001/archinte.168.15.1617.
  • Bhaskaran, K et al, “Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK” Lancet Diabetes Endocrinol. 2018 Dec; 6(12): 944–953. doi: 10.1016/S2213-8587(18)30288-2.
Vai šis raksts jums šķita noderīgs?

Jums varētu patikt

Skatīt citus saistītos rakstus